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cnrs-orleans.fr (M. Genest), norbert.garnier@cnrs-orleTo address the question of ligand entry process, we report targeted molecular dynamics simulations
of the entry of the ﬂexible ionic ligand GW0072 in the ligand binding domain of the nuclear receptor
PPARc. Starting with the ligand outside the receptor the simulations led to a ligand docked inside
the binding pocket resulting in a structure very close to the holo-form of the complex. The results
showed that entry process is guided by hydrophobic interactions and that entry pathways are very
similar to exit pathways. We suggest that TMD method may help in discriminating between ligands
generated by in silico docking.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Docking is an in silico structure-based drug design technique
used to select ligands with the best afﬁnity for the binding site of
a given receptor. Generally this is achieved by searching the most
favourable orientation of each member of a set of molecules within
a rigid binding site with the most favourable stability. Ligands hav-
ing good afﬁnity are called positive ligands contrarily to those hav-
ing bad afﬁnity which are called negative ligands. Current docking
programs (for a list of some docking programs see [1]) take ligand
ﬂexibility into account while the receptor is considered rigid or
partially rigid, allowing side chain ﬂexibility. The risk of neglecting
receptor ﬂexibility is the determination of false negative ligands.
Simulationmethods such as Molecular Dynamics (MD) and Normal
Modes analysis (NM) may improve the search for potentially active
ligands, but the question of the pathway for the ligand to reach the
binding site within the receptor is not addressed. Nevertheless, the
knowledge of ligand pathways represents an important component
of ligand afﬁnity, since high energy barriers may prevent the ligand
from reaching the binding site, thus leading to false positive li-
gands being deﬁned.
The determination of ligand entry pathways is a difﬁcult task,
both experimentally and computationally. Simulation studies have
proved helpful in ﬁnding pathways for a ligand to escape from a
receptor [2–6], but only a few studies deal with ligand entry path-
ways [7–10]. Obviously, escape and entry pathways are a priori not
identical.chemical Societies. Published by E
ci-Sèche), monique.genest@
ans.fr (N. Garnier).To address the question of the ligand entry process, we report
here Targeted Molecular Dynamics (TMD) simulations of the bind-
ing of the GW0072 ligand with the ligand binding domain (LBD) of
the Peroxysome Proliferator-Activated Receptor gamma (PPARc).
This receptor from the superfamily of nuclear receptor is a phar-
macological target for a number of diseases [11]. We were moti-
vated to study this complex because (i) GW0072 is a large ionic
highly ﬂexible ligand including aliphatic and polar groups [12],
and (ii) previous simulations have deﬁned possible escape path-
ways for this ligand [6]. Starting from the apo-form of the receptor
(PDB.ID 1PRG, A chain) [13] with the ligand located outside, TMD
simulations converge close to the targeted structure of the holo-
form of the complex (PDB.ID 4PRG, A chain) [12] deﬁning a
penetration pathway into the binding pocket that is very similar
to escape pathways [6].
2. Methods
All the simulations were performed in the presence of explicit
water molecules and Na+ counterions using the parallelized ver-
sion of the SANDER program from the AMBER 9.0 package [14].
The simulation protocol follows that described in our previous
study [6] and is given in Supplementary material (Text T1).
In TMD simulation, a group of atoms is guided from an initial
structure toward a target structure by decreasing step by step the
root mean square deviation (RMSD) between the two structures
[15]. In this study the initial structure of the receptor is the X-ray
structure of the apo-formof the LBDof PPARc (PDB.ID 1PRG, A Chain
[13]). The initial conformation of GW0072 was generated by a con-
formational search using MacroModel and placed near gate A iden-
tiﬁed previously as the most probable exit gate [6] and also becauselsevier B.V. All rights reserved.
Fig. 1. Chemical structure of the GW0072 ligand.
Fig. 2. Time evolution of the RMSD calculated on the backbone heavy atoms of the
binding site and all the atoms of the ligand, relative to the targeted structure:
TMD_DP (black) and TMD_P (blue).
Fig. 3. Interaction energies between the ligand and the receptor in TMD_DP (black)
and TMD_P (blue) simulations.
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keep in mind that other gates could exist. The targeted structure is
the X-ray structure of PPARc bound to the GW0072 ligand (PDB.ID
4PRG, A chain [12]). Because of uncertainties on proton exchange
during ligand entry, two distinct simulations were conducted, one
with theprotonated formofGW0072 (TMD_P) (carboxyl protonated
head, Fig. 1) and the other one with the deprotonated form
(TMD_DP). Constraints were applied on all the ligand atoms and
on the backbone heavy atoms of the residues of the binding site that
were deﬁned as the residues having at least one atom separated by
less than 3.5 Å from any atom of the ligand in the holo form of
PPARc. The remainder of the protein was not restrained.
After minimization, heating and equilibration at 300 K, the
RMSD on the set of selected atoms calculated between the equili-
brated conformation and the target were 17.4 Å and 18.5 Å for
TMD_DP and TMD_P, respectively. During TMD simulation, the
RMSD value was constrained to decrease progressively by steps
of 0.085 Å and 0.09 Å, respectively, every 50 ps and was approxi-
mately 0.4 Å and 0.5 Å after 10 ns. This was followed by 14 ns of
free simulation for system relaxation.
The RMSD and atomic ﬂuctuations were monitored using the
PTRAJ program. Hydrogen bond occupancy was calculated using
the HBonds plugin included in the Visual Molecular Dynamics soft-
ware (VMD) [16] using a 3.2 Å cut-off for the donor–acceptor dis-
tance and a donor-hydrogen-acceptor angle lower than 65.
Energy calculations were performed with the MM-PBSA module
and protein–ligand hydrophobic interactions were analysed and
visualizedusing Ligplot [17]. Amaximal separation of 3.9 Åbetween
the two atoms is used to deﬁne these hydrophobic interactions.
3. Results
TMD_P and TMD_DP both successfully led to the formation of a
stable protein–ligand complex. During the 14 ns of free simula-
tions the ligand remained docked inside the binding site. A contin-
uous decrease in the RMSD was observed during the TMD period
(Fig. 2) along with a weak constrained energy (lower than
10 kcal/mol except for the last 500 ps). During the relaxation per-
iod, the RMSD stabilized around 2–3 Å.
3.1. Energetics
Fig. 3 shows the evolution of the interaction energies between
the ligand and the receptor during the entry process (0–10 ns)
and the relaxation period (10–24 ns). During the entry processthe energy value continuously decreases from 0 kcal mol1 to
about 55 kcal mol1. Interestingly, for both ligand states, no en-
ergy barrier was detected until the ligand reaches the binding site
(0–9.5 ns). After 8 ns, the alkyl chain and the aromatic core are
placed in the binding site. Then, the positioning of the polar head
leads to an energetic drop (8–9.5 ns). For the last 0.5 ns
(9.5–10 ns) the constraints applied on the ligand to adjust the tar-
get conformation results in a small energetic rise. In the course of
the relaxation period (10–24 ns), the interaction energy ﬂuctuates
around the mean value 61 kcal mol1 (TMD_P) or 53 kcal mol1
(TMD_DP). This energy is slightly more favourable for the proton-
ated ligand than for the deprotonated one.
3.2. Internal dynamics during TMD simulations
The internal dynamics of the receptor during the entry process
is revealed by the ﬂuctuations of the Ca atom positions as shown in
Fig. 4. Several high peaks evidence large atomic ﬂuctuations
(excluding end effects). The highest peaks involve the loop joining
helix H2 and the ﬁrst strand S1 of the b sheet, helix H20 and the
H20–H3 loop. These two peaks were observed in both simulations.
Two lower peaks correspond to the loops joining the two helices
H8 and H9 and helices H9 and H10/H11. Another region with
moderate ﬂuctuations containing H50 and H6 and the S3 and S4
Fig. 4. Ca atomic ﬂuctuations during the 10 ns TMD period of the TMD_DP (black)
and TMD_P (blue) simulations.
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shown in Fig. 5. Interestingly, these regions overlap the border of
gate A pointed out during the exit pathway process [6].Fig. 5. Worm representation of the ﬂexible regions of LBD PPAR observed during the TMD
and residues with high atomic ﬂuctuations are in red.
Fig. 6. (A) Ligand entry pathways determined from TMD_DP (sky blue)3.3. Entry/exit pathways
The two ligand entry pathways determined in the present study
and the probable ligand escape pathways [6] are compared in
Fig. 6. It can be seen that the ligand entry routes are very similar
to ﬁve of the six exit pathways through gate A, regardless of the li-
gand protonation state. There is, however, a difference in the vicin-
ity of the H50 helix. In TMD_DP, the ligand avoids H50 to ﬁnd the
best route, while during TMD_P, helix H50 is pushed away by the
ligand and partially loses its helical structure, allowing ligand en-
try. Once the ligand enters the binding site, H50 recovers its helical
structure which remains stable throughout the 14 ns of the relax-
ation period. The role played by this helix in the closing gate pro-
cess was already revealed in our ligand escape pathway study [6].
During the ﬁrst steps of the entry process, the ligand rotates on
itself in order to guide the hydrophobic region close to the entry
site. In both simulations it is observed that the alkyl chain tends
to enter ﬁrst, coming into contact with helix H50. In TMD_DP this
small helix is easily bypassed by the alkyl chain followed by the
benzyl groups. On the contrary, in TMD_P, the alkyl group is
blocked until the benzyl groups ﬁrst bypass H50, driving thereafter
the alkyl chain deeper into the protein. In both cases, the carbox-
ylic polar head remains in contact with the solvent as long as
possible.phase: (A) TMD_DP; (B) TMD_P. Residues with low atomic ﬂuctuations are in blue
and TMD_P (deep-blue) and (B) escape pathways described in [6].
Table 2
Hydrogen bonds observed in the course of TMD_DP and TMD_P compared to the
hydrogen bonds in the X-ray structure.
Hbond donor Hbond acceptor 4PRG (X-ray) TMD_DP TMD_P
Ser342 GW0072 100 12.9 0.7
Arg288 GW0072 100 0.6 0.3
GW0072 Glu259 0 0.0 0.0
Arg280 GW0072 0 0.0 87.8
Lys263 GW0072 0 46.5 0.0
GW0072 Leu255 0 0.0 61.3
Cys285 GW0072 0 3.7 4.3
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Table 1 summarizes the protein–ligand hydrophobic interac-
tions of the most central structure of the complex for both forms
of the ligand during the relaxation period. For comparison, the 18
hydrophobic interactions detected in the X-ray structure of the
complex (4PRG chain A) are also reported. Only 10 of these inter-
actions were detected in the central structure generated by TMD_P
and 8 in the case of TMD_DP. Six are shared by the X-ray structure
and the TMD_P and TMD_DP central structures. Residues in inter-
action with the aromatic core of GW0072 are remarkably well con-
served in both simulations, contrarily to the residues interacting
with the aliphatic and carboxyphenyl groups. Indeed, as shown
in Fig. 7, the positions of the aromatic core in the three structures
are well superimposed and located in the hydrophobic pocket.Table 1
Protein–ligand hydrophobic interactions in the X-ray structure and in the central
structure of the TMD_DP and TMD_P relaxation period. Interactions with the aromatic
core are in bold: those common to the three structures are labeled , others are in
italics.
4PRG (X-ray) TMD_P TMD_DP
Leu255 – –
– – Ile262
Phe264 Phe264 –
His266 His266 –
Ala278 – –
Arg280 – –
Ile281 Ile281 –
Cys285⁄ Cys285⁄ Cys285⁄
Arg288⁄ Arg288⁄ Arg288⁄
Ile326 Ile326 –
Tyr327⁄ Tyr327⁄ Tyr327⁄
Met329⁄ Met329⁄ Met329⁄
Leu330⁄ Leu330⁄ Leu330⁄
Leu333⁄ Leu333⁄ Leu333⁄
– Val339
Ile341 – Ile341
Leu356 – –
Phe360 – –
Phe363 – –
Met364 – Met364
– His449 –
Fig. 7. Superimposition of the central structures calculated from the relaxation
period for the TMD_DP (cyan) and TMD_P simulations (pink) onto the X-ray
structure (gray).Protein–ligand H-bonds have been also analyzed and are given
in Table 2. The two intermolecular H-bonds present in the X-ray
structure, involving Ser342 and Arg288, are seen as very transitory
events during the two simulations. One major H-bond was de-
tected in the TMD_DP simulation, present during 47% of the relax-
ation time and involving Lys263. Two important H-bonds are
highlighted in the TMD_P simulation occurring for 88% and 61%
of the relaxation time and involving Arg280 and Leu255,
respectively.
3.5. Discussion and conclusion
Simulationmethods are proved helpful to describe ligand escape
pathways from their binding site located in a protein pocket [2–6],
but very few studies have addressed the ligand entry process into
receptors. The present work aimed to tackle this point which is
rather difﬁcult when considering the large and ﬂexible ligand
GW0072, a 90-atom molecule containing a carboxyl head, an ali-
phatic chain and an aromatic core (Fig. 1) and its receptor, the LBD
of PPARc. The X-ray structures of the protein with and without the
ligand are available in the Protein Data Bank (www.pdb.org [18])
and exit pathways were determined from MD simulations [6].
In this work we evidence two very similar entry pathways for
GW0072 using TMD simulations and we focus on two aspects: (i)
the similarity or the difference of entry/exit pathways; (ii) the
presence of energy barriers during the entry process. The inﬂuence
of the protonation state of GW0072 has also been investigated.
Using the TMD approach [15] the initial system including the
apo-form of the receptor and the ligand outside was targeted on
the X-ray structure of the holo-form of the complex. The two sim-
ulations carried out with the protonated and deprotonated forms
of the ligand led to the formation of a stable complex although
the orientation of the ligand polar heads differed in the binding
pocket. Entry pathways were found identical for the two states of
the ligand without an energy barrier during the entry process. A
very interesting result is that these entry pathways are very similar
to the main exit pathway described in our previous study [6]. Of
course, this ﬁnding may be different for other receptors and other
ligands.
Both the motion of the ligand before entering the receptor for
guiding ﬁrst the hydrophobic part at the entry gate and the way
the ligand ﬁnally anchors in the hydrophobic pocket strongly sug-
gest that the entry process in LBD is mainly governed by hydropho-
bic interactions. However, polar interactions play a role in the
stabilization of the ligand. Two strong H-bonds involving Leu255
and Arg280 are observed in TMD_P while a unique weak H-bond
involving Lys263 is observed in TMD_DP. Thus, the protonated
form of the ligand is slightly more stable than the deprotonated
form and this difference in stability could be related to the desolv-
ation of the carboxyl head of the ligand which could be a rate lim-
iting step of the ligand insertion [9].
It is also important to note the very different behaviour of helix
AF-2 during the entry phase and the relaxation phase. Obviously,
there is no direct interaction between GW0072 and AF-2 during
S. Aci-Sèche et al. / FEBS Letters 585 (2011) 2599–2603 2603the ligand entry process. But while GW0072 enters the receptor
(Fig. 5) the helix is very mobile and once the ligand is placed in
the pocket AF-2 becomes much less ﬂexible during the rest of
the simulation (Fig. S1 in Supplementary material). This ﬁnding
is in good agreement with the observation of Oberﬁeld et al. [12]
suggesting that although there is no direct interactions with the li-
gand, its presence in the binding site stabilizes AF-2 in an interme-
diate conformation which could be responsible of the properties of
partial agonist for GW0072.
In this work we have shown that TMD can drive the GW0072-
PPARc system from an unbound form to the bound form. Starting
with the ligand outside the receptor, the simulations led to a ligand
docked inside the binding pocket, resulting in a structure very
close to that of an a priori known structure. However, the question
arises whether the same result would be obtained if the structure
of the complex were unknown. To answer this question, comple-
mentary MD simulations, starting from the same initial complex,
were performed during which the distance between the centers
of mass of the ligand and of the binding site was progressively con-
strained to decrease (not detailed here). This simulation success-
fully led to a ﬁnal structure close to the holo-form of the
complex (PDB.ID 4PRG) and the ligand entry pathway was globally
superimposed on that found from TMD simulations.
The results reported here are encouraging and suggest that the
TMD method is helpful in discriminating between ligands gener-
ated by in silico docking. It can be considered that a molecule with
high afﬁnity related to strong binding site interactions and there-
fore declared as an agonist or antagonist candidate would be elim-
inated if its entry pathway into the receptor evidences high energy
barriers.
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